NCT04588519View on ClinicalTrials.gov

tAN to Mitigate Withdrawal Behaviors in Neonates

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 30, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

December 30, 2020

Conditions
Neonatal Abstinence Syndrome
Interventions
DEVICE

Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System

Spark Roo tAN System programmed to a pulse width of 250ms; channel 1: 5 Hz, mean intensity 0.3±0.2 mA; channel 2: 100 Hz, mean intensity 0.6±0.2 mA.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

Medical University of South Carolina

OTHER

lead

Spark Biomedical, Inc.

INDUSTRY

NCT04588519 - tAN to Mitigate Withdrawal Behaviors in Neonates | Biotech Hunter | Biotech Hunter